Radiation Dose-Volume Effects for Liver SBRT.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29482870.
- Also identified by DOI 10.1016/j.ijrobp.2017.12.290 and PMC identifier 6095822.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stereotactic body radiation therapy (SBRT) has emerged as an effective, noninvasive treatment option for primary liver cancer and metastatic disease occurring in the liver. Although SBRT can be highly effective for establishing local control in hepatic malignancies, a tradeoff exists between tumor control and normal tissue complications. The objective of the present study was to review the normal tissue dose-volume effects for SBRT-induced liver and gastrointestinal toxicities and derive normal tissue complication probability models.
Medical subject headings
- Gastrointestinal Tract
- Liver
- Liver Neoplasms
- Organs at Risk
- Radiosurgery